Table 3.
Region | PWV femoral | AIx-75 | BrachD |
---|---|---|---|
Intercept | 7.92 (5.48, 10.36) | ||
Age (baseline) | 0.10 (0.05, 0.15) | ||
Gender (female vs. male) | −0.23 (−0.43, −0.04) | 0.52 (0.22, 0.82) | |
BMI, kg/m2 | −0.41 (−0.67, −0.16) | ||
Height, cm | −0.34 (−0.50, −0.17) | ||
MAP, mm Hg | 0.03 (0.01, 0.04) | 0.32 (0.13, 0.51) | |
Total cholesterol, mg/dL | 0.08 (0.03, 0.13) | ||
Heart rate, beats per minute | 0.01 (3.61E-03, 0.02) | −0.02 (−0.03, −0.01) | |
Waist circumference, cm | 0.02 (0.01, 0.04) | ||
Model R2 | 0.51 | 0.30 | 0.31 |
Multiple linear regression with β coefficient and confidence intervals for β. All covariates were allowed to enter the model except height but not heart rate for AIx-75. Only significant covariates are listed above, p < 0.05. Models were adjusted for clinic site and time difference between visits. Alx-75, augmentation index; BMI, body mass index; BrachD, brachial distensibility; MAP, mean arterial pressure; PWV, pulse wave velocity.